거래량 | 0 |
|
|||||
뉴스 | - |
Moringa Acquisition Corporation
시가총액 | 발행 주식 | Float | 매출 | 이익/손실 | EPS | 주가수익률 |
---|---|---|---|---|---|---|
38.01M | 3.36M | - | 0 | 263k | 0.08 | 144.52 |
공매도 잔량 | 주당 배당금 | 배당수익률 | 배당락일 | 인사이더 B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Moringa Acquisition
Date | Time | Source | Heading |
---|---|---|---|
27/02/2024 | 07:29 | Edgar (US Regulatory) | Form 8-K - Current report |
27/02/2024 | 07:29 | Edgar (US Regulatory) | Form 8-K - Current report |
22/02/2024 | 22:27 | GlobeNewswire Inc. | Silexion, a Clinical-Stage, Oncology-Focused Biotechnology.. |
15/11/2023 | 06:06 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
23/08/2023 | 05:05 | Edgar (US Regulatory) | Form 8-K - Current report |
16/08/2023 | 22:27 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
15/08/2023 | 22:27 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
15/08/2023 | 22:26 | Edgar (US Regulatory) | Form 8-K - Current report |
15/08/2023 | 22:25 | GlobeNewswire Inc. | MORINGA ACQUISITION CORP ANNOUNCES CONTRIBUTION TO TRUST.. |
15/08/2023 | 05:05 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
11/08/2023 | 05:10 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
11/08/2023 | 05:05 | Edgar (US Regulatory) | Form 8-K - Current report |
MACAU Historical
기간 | 시가 | 고가 | 저가 | VWAP | 평균 일일 거래량 | 변동 | % |
---|---|---|---|---|---|---|---|
1주 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1개월 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3개월 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6개월 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1년 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3년 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5년 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |